Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2026-01-29 @ 2:50 AM
Study NCT ID:
NCT02504294
Status:
COMPLETED
Last Update Posted:
2018-06-13
First Post:
2015-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-16
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-20
First Submit QC Date:
None
Study First Post Date:
2015-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-16
Results First Submit QC Date:
None
Results First Post Date:
2018-06-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-09-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-05-16
Last Update Post Date:
2018-06-13
Last Update Post Date Type:
ACTUAL